Thank you to everyone who joined today’s Mito-Hackers webinar with Dr. Francisco Villarreal.
The session examined how the evidence for (−)-epicatechin compares with that available for other compounds commonly associated with mitochondrial health.
Rather than relying on a single experiment or outcome, Dr. Villarreal reviewed the evidence across several levels, including pharmacology, molecular mechanisms, preclinical research, human studies, large population studies, and longevity research. A central theme was that compounds should be evaluated by the breadth, consistency, and quality of the research behind them, not simply by their popularity or marketing claims.
The Q&A covered supplement purity and dosing, how (−)-epicatechin is absorbed and metabolized, safety considerations, and its relationship to mitochondrial function and oxidative stress.
For those interested in taking a deeper look, our Supplement Comparison page examines how (−)-epicatechin compares with other commonly discussed compounds across evidence, mechanisms, safety, and practical use.
The video recording will be added to the Webinars & Events space soon.
For now, we’d love to hear from you:
Which type of evidence matters most to you when evaluating a supplement: biological mechanisms, human trials, long-term population data, or something else?